{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["CD4+ T cells", "Ozonated autohemotherapy", "PPAR-\u03b3", "hyperlipidemia", "psoriasis"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33527029", "DateRevised": {"Year": "2021", "Month": "02", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "01", "Day": "15"}], "ELocationID": [], "Journal": {"ISSN": "1943-8141", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2021"}}, "Title": "American journal of translational research", "ISOAbbreviation": "Am J Transl Res"}, "ArticleTitle": "Ozonated autohemotherapy elevates PPAR-\u03b3 expression in CD4<sup>+</sup> T cells and serum HDL-C levels, a potential immunomodulatory mechanism for treatment of psoriasis.", "Pagination": {"StartPage": "349", "EndPage": "359", "MedlinePgn": "349-359"}, "Abstract": {"AbstractText": ["Psoriasis is widely accepted as a metabolic syndrome with significantly abnormal lipid metabolism and high level of blood lipids that induce a persistent low level of inflammatory condition in patients. T cell mediated immune response plays a critical role in the occurrence and persistence of psoriasis lesions. Hyperlipidemia and associated inflammatory reaction are believed to be the major risk factors for the onset and recurrence of psoriasis. Peroxisome proliferator activated receptor-gamma (PPAR-\u03b3) is known to effectively regulate the blood lipid level and inhibit inflammatory reaction. In this study, we examined the efficacy of ozonated autohemotherapy (OAHT) treatment on psoriatic patients by evaluating the Psoriasis Area and Severity Index (PASI) score and blood lipid level. In addition, PPAR-\u03b3 expression level and the correlation of PASI scores or blood lipid level with the PPAR-\u03b3 expression were also assessed to determine the psoriasis-associate targets of OAHT. We found that OAHT significantly decreased patients' PASI scores and increased blood HDL-C level. Furthermore, we found that PPAR-\u03b3 expression in CD4<sup>+</sup> T cells from psoriasis patients was significantly lower than healthy controls, and OAHT treatment increased the expression of PPAR-\u03b3. In conclusion, OAHT attenuates the psoriatic severity in patients and increased blood HDL-C level, which may be associated with increased PPAR-\u03b3 expression. Our data suggests that OAHT is an effective treatment in psoriasis and deserves further evaluations in clinical applications."], "CopyrightInformation": "AJTR Copyright \u00a9 2021."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Zeng", "ForeName": "Jinrong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Tang", "ForeName": "Zhen", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xiangya School of Medicine, Central South University Changsha, Hunan, China."}], "LastName": "Zhang", "ForeName": "Yuezhong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Tong", "ForeName": "Xiaoliang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Dou", "ForeName": "Jianhua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Gao", "ForeName": "Lihua", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Ding", "ForeName": "Shu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Third Xiangya Hospital, Central South University Changsha, Hunan, China."}], "LastName": "Lu", "ForeName": "Jianyun", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Transl Res", "NlmUniqueID": "101493030", "ISSNLinking": "1943-8141"}, "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gisondi P, Fostini AC, Fossa I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36:21\u201328.", "ArticleIdList": ["29241748"]}, {"Citation": "Carrascosa JM, Rocamora V, Fernandez-Torres RM, Jimenez-Puya R, Moreno JC, Coll-Puigserver N, Fonseca E. Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications. Actas Dermosifiliogr. 2014;105:31\u201344.", "ArticleIdList": ["23177976"]}, {"Citation": "He L, Qin S, Dang L, Song G, Yao S, Yang N, Li Y. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein. Biochim Biophys Acta. 2014;1841:1709\u20131715.", "ArticleIdList": ["25240836"]}, {"Citation": "Marechal L, Laviolette M, Rodrigue-Way A, Sow B, Brochu M, Caron V, Tremblay A. The CD36-PPARgamma pathway in metabolic disorders. Int J Mol Sci. 2018;19:1529\u20131544.", "ArticleIdList": ["PMC5983591", "29883404"]}, {"Citation": "Siersbaek R, Nielsen R, Mandrup S. PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies. FEBS Lett. 2010;584:3242\u20133249.", "ArticleIdList": ["20542036"]}, {"Citation": "Zeng J, Lu J. Mechanisms of action involved in ozone-therapy in skin diseases. Int Immunopharmacol. 2018;56:235\u2013241.", "ArticleIdList": ["29414657"]}, {"Citation": "Buyuklu M, Kandemir FM, Set T, Bakirci EM, Degirmenci H, Hamur H, Topal E, Kucukler S, Turkmen K. Beneficial effects of ozone therapy on oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction. Cardiovasc Toxicol. 2017;17:426\u2013433.", "ArticleIdList": ["28097518"]}, {"Citation": "Delgado-Roche L, Martinez-Sanchez G, Re L. Ozone oxidative preconditioning prevents atherosclerosis development in New Zealand White rabbits. J Cardiovasc Pharmacol. 2013;61:160\u2013165.", "ArticleIdList": ["23222311"]}, {"Citation": "Reich K, Gooderham M, Thaci D, Crowley JJ, Ryan C, Krueger JG, Tsai TF, Flack M, Gu Y, Williams DA, Thompson EHZ, Paul C. Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial. Lancet. 2019;394:576\u2013586.", "ArticleIdList": ["31280967"]}, {"Citation": "Marx N, Kehrle B, Kohlhammer K, Gr\u00fcb M, Koenig W, Hombach V, Libby P, Plutzky J. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res. 2002;90:703\u2013710.", "ArticleIdList": ["PMC4231718", "11934839"]}, {"Citation": "Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 2012;9:302\u2013309.", "ArticleIdList": ["PMC4132586", "22705915"]}, {"Citation": "Zhao M, Wang LT, Liang GP, Zhang P, Deng XJ, Tang Q, Zhai HY, Chang CC, Su YW, Lu QJ. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. Clin Immunol. 2014;150:22\u201330.", "ArticleIdList": ["24316592"]}, {"Citation": "Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol. 1995;105:89S\u201394S.", "ArticleIdList": ["7616005"]}, {"Citation": "Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007;117:1119\u20131127.", "ArticleIdList": ["PMC1857272", "17476341"]}, {"Citation": "Krueger JG. Hiding under the skin: a welcome surprise in psoriasis. Nat Med. 2012;18:1750\u20131751.", "ArticleIdList": ["23223064"]}, {"Citation": "Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol. 2010;130:1373\u20131383.", "ArticleIdList": ["PMC2892169", "20032993"]}, {"Citation": "Taheri Sarvtin M, Hedayati MT, Shokohi T, HajHeydari Z. Serum lipids and lipoproteins in patients with psoriasis. Arch Iran Med. 2014;17:343\u2013346.", "ArticleIdList": ["24784863"]}, {"Citation": "Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Stahle M, Nestle FO, Girolomoni G, Krueger JG. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130:1785\u20131796.", "ArticleIdList": ["20445552"]}, {"Citation": "Salama RH, Al-Shobaili HA, Al Robaee AA, Alzolibani AA. Psoriasin: a novel marker linked obesity with psoriasis. Dis Markers. 2013;34:33\u201339.", "ArticleIdList": ["PMC3809746", "23151615"]}, {"Citation": "Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Barba A, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61\u201367.", "ArticleIdList": ["15982303"]}, {"Citation": "Wolk K, Sabat R. Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations. Rev Endocr Metab Disord. 2016;17:305\u2013317.", "ArticleIdList": ["27554109"]}, {"Citation": "Exley MA, Hand L, O\u2019Shea D, Lynch L. Interplay between the immune system and adipose tissue in obesity. J Endocrinol. 2014;223:R41\u201348.", "ArticleIdList": ["25228503"]}, {"Citation": "Huang H, Shen E, Tang S, Tan X, Guo X, Wang Q, Ding H. Increased serum resistin levels correlate with psoriasis: a meta-analysis. Lipids Health Dis. 2015;14:44\u201352.", "ArticleIdList": ["PMC4451955", "25980409"]}, {"Citation": "Nakajima H, Nakajima K, Tarutani M, Sano S. Clear association between serum levels of adipokines and T-helper 17-related cytokines in patients with psoriasis. Clin Exp Dermatol. 2013;38:66\u201370.", "ArticleIdList": ["23083105"]}, {"Citation": "Ivanova EA, Parolari A, Myasoedova V, Melnichenko AA, Bobryshev YV, Orekhov AN. Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery. J Cardiol. 2015;66:271\u2013278.", "ArticleIdList": ["26072262"]}, {"Citation": "Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 2005;437:759\u2013763.", "ArticleIdList": ["PMC1464798", "16127449"]}, {"Citation": "Kotla S, Rao GN. Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-gamma in CD36 protein expression and foam cell formation. J Biol Chem. 2015;290:30306\u201330320.", "ArticleIdList": ["PMC4683256", "26504087"]}, {"Citation": "Luther J, Ubieta K, Hannemann N, Jimenez M, Garcia M, Zech C, Schett G, Wagner EF, Bozec A. Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARgamma and hypoxia. Cell Death Differ. 2014;21:655\u2013664.", "ArticleIdList": ["PMC3950327", "24464219"]}, {"Citation": "Park HJ, Park HS, Lee JU, Bothwell AL, Choi JM. Sex-based selectivity of PPARgamma regulation in Th1, Th2, and Th17 differentiation. Int J Mol Sci. 2016;17:1347\u20131357.", "ArticleIdList": ["PMC5000743", "27548145"]}, {"Citation": "Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 2012;486:549\u2013553.", "ArticleIdList": ["PMC3387339", "22722857"]}, {"Citation": "Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O\u2019Neill MC, Zinman B, Viberti G ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427\u20132443.", "ArticleIdList": ["17145742"]}, {"Citation": "Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lef\u00e8bvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Kor\u00e1nyi L, Laakso M, Mok\u00e1n M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J PROactive Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial In macroVascular events): a randomised controlled trial. Lancet. 2005;366:1279\u20131289.", "ArticleIdList": ["16214598"]}, {"Citation": "Kersten S. Peroxisome proliferator activated receptors and lipoprotein metabolism. PPAR Res. 2008;2008:132960\u2013132970.", "ArticleIdList": ["PMC2220040", "18288277"]}, {"Citation": "Tan L, Huang J, Lu J, Lu J. Clinical efficacy of ozonated oil in the treatment of psoriasis vulgaris. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:173\u2013178.", "ArticleIdList": ["29559602"]}, {"Citation": "Larini A, Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol In Vitro. 2005;19:55\u201361.", "ArticleIdList": ["15582356"]}, {"Citation": "Tylicki L, Niew glowski T, Biedunkiewicz B, Burakowski S, Rutkowski B. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study. Int J Artif Organs. 2001;24:79\u201382.", "ArticleIdList": ["11256512"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "6", "Day": "12"}, {"Year": "2020", "Month": "11", "Day": "11"}, {"Year": "2021", "Month": "2", "Day": "2", "Hour": "6", "Minute": "10"}, {"Year": "2021", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["33527029", "PMC7847517"]}}], "PubmedBookArticle": []}